Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study - Concepedia

Concepedia

Publication | Open Access

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study

DOI Full Paper Access

70

Citations

29

References

2013

Year

Eliot A. Brinton, Christie M. Ballantyne, Harold Bays, John J.P. Kastelein, Rene A. Braeckman, Paresh N. Soni

Cardiovascular Diabetology

Abstract

Clinicaltrials.gov Identifier NCT01047501.

References

	Year	Citations

Page 1